Ann: March 2025 Quarterly Activities Report and Appendix 4C, page-175

thanks da chopper I get ya points in valuation and appreciate your analysis and don't disagree with it I just think with all the uncertainty around tariffs, business investment and paying a 900% premium for a single drug company after 6 months of sales is too much to ask. I notice another poster said 1 month I'm just going to kick back and hope the business keeps growing as expected rest is a bonus. I do hope ya right re T/O just I can't see it next quarter.
I do have a concern on insurance payments and coverage - I know we have signed up or Sofdra is approved but is that locked in and for how long - the cost of sofdra is greater than or about the same as annual avergae insurance premiums per person. it doesn't seem good business for insurance companies - one off yes but continuous refills would be bad for thier business model I would think . not sure how it all works over there but I do have that risk in the back of my mind. if anyone knows or sees it differently love to hear - want to buy more but trying to get my head around that long term - thanks in advance